BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34694921)

  • 1. Association Between Time to First RNA-Negative Test Result Among People With Hepatitis C Virus Infection and Homelessness or Testing at a Correctional or Substance Use Treatment Facility, New York City.
    Moore MS; Bocour A
    Public Health Rep; 2022; 137(6):1126-1135. PubMed ID: 34694921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of criminal justice and substance use treatment involvement with HIV/HCV testing and the HIV treatment cascade among people who use drugs in Oakland, California.
    Lambdin BH; Kral AH; Comfort M; Lopez AM; Lorvick J
    Addict Sci Clin Pract; 2017 Jun; 12(1):13. PubMed ID: 28610602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department.
    Hutton J; Doyle J; Zordan R; Weiland T; Cocco A; Howell J; Iser S; Snell J; Fry S; New K; Sloane R; Jarman M; Phan D; Tran S; Pedrana A; Williams B; Johnson J; Glasgow S; Thompson A
    Int J Drug Policy; 2019 Oct; 72():84-90. PubMed ID: 31351752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston.
    Beiser ME; Shaw LC; Shores SK; Carson JM; Hajarizadeh B
    Clin Infect Dis; 2023 Jul; 77(1):46-55. PubMed ID: 36869823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London.
    Aisyah DN; Shallcross L; Hayward A; Aldridge RW; Hemming S; Yates S; Ferenando G; Possas L; Garber E; Watson JM; Geretti AM; McHugh TD; Lipman M; Story A
    J Viral Hepat; 2018 Nov; 25(11):1260-1269. PubMed ID: 29851232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of an integrated nurse model of care providing hepatitis C treatment to people attending homeless services in Melbourne, Australia.
    Harney BL; Whitton B; Lim C; Paige E; McDonald B; Nolan S; Pemberton D; Hellard ME; Doyle JS
    Int J Drug Policy; 2019 Oct; 72():195-198. PubMed ID: 30981613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Test uptake and hepatitis C prevalence in 5483 Danish people in drug use treatment from 1996 to 2015: a registry-based cohort study.
    Øvrehus A; Nielsen S; Hansen JF; Holm DK; Christensen P
    Addiction; 2019 Mar; 114(3):494-503. PubMed ID: 30347471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility.
    MacIsaac MB; Whitton B; Hubble A; Cogger S; Penn M; Weeks A; Elmore K; Pemberton D; Anderson J; Howard R; McKeever U; Papaluca T; Hellard ME; Stoove M; Wilson D; Pedrana A; Doyle J; Clark N; Holmes J; Thompson AJ
    Med J Aust; 2023 Apr; 218(6):256-261. PubMed ID: 36919230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study.
    Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J;
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C and substance use in a sample of homeless people in New York City.
    Rosenblum A; Nuttbrock L; McQuistion HL; Magura S; Joseph H
    J Addict Dis; 2001; 20(4):15-25. PubMed ID: 11760923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.
    Bajis S; Grebely J; Cooper L; Smith J; Owen G; Chudleigh A; Hajarizadeh B; Martinello M; Adey S; Read P; Gilliver R; Applegate T; Treloar C; Maher L; Dore GJ
    J Viral Hepat; 2019 Aug; 26(8):969-979. PubMed ID: 30980785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health Department Efforts to Increase Hepatitis C RNA Testing Among People Appearing Out of Care: Comparison of Outreach Approaches, New York City, 2017.
    Webster R; Moore MS; Bocour A; Johnson N; Winters A
    Public Health Rep; 2020; 135(6):823-830. PubMed ID: 32886566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and gender-specific hepatitis C continuum of care and predictors of direct acting antiviral treatment among persons who inject drugs in Seattle, Washington.
    Corcorran MA; Tsui JI; Scott JD; Dombrowski JC; Glick SN
    Drug Alcohol Depend; 2021 Mar; 220():108525. PubMed ID: 33461152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use.
    Des Jarlais DC; Arasteh K; Feelemyer J; McKnight C; Barnes DM; Perlman DC; Uuskula A; Cooper HLF; Tross S
    Drug Alcohol Depend; 2018 Nov; 192():74-79. PubMed ID: 30243142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results: A Randomized Trial.
    Frimpong JA; Shiu-Yee K; Tross S; D'Aunno T; Perlman DC; Strauss SM; Schackman BR; Feaster DJ; Metsch LR
    Med Care; 2020 May; 58(5):445-452. PubMed ID: 32040038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
    Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
    Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Surveillance-Based Hepatitis C Care Cascade, New York City, 2017.
    Moore MS; Bocour A; Laraque F; Winters A
    Public Health Rep; 2018; 133(4):497-501. PubMed ID: 29902392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk behaviours of homeless people who inject drugs during an outbreak of hepatitis C, Northern Ireland, 2016-2017.
    Maisa A; Semple S; Griffiths A; Ngui SL; Verlander NQ; McCaughey C; Doherty L; Jessop L;
    J Viral Hepat; 2019 Dec; 26(12):1377-1387. PubMed ID: 31328838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV-HCV co-infected patients in Canada.
    Kronfli N; Nitulescu R; Cox J; Moodie EE; Wong A; Cooper C; Gill J; Walmsley S; Martel-Laferrière V; Hull MW; Klein MB;
    J Int AIDS Soc; 2018 Nov; 21(11):e25197. PubMed ID: 30460791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study.
    Mendlowitz AB; Bremner KE; Krahn M; Walker JD; Wong WWL; Sander B; Jones L; Isaranuwatchai W; Feld JJ
    CMAJ; 2023 Apr; 195(14):E499-E512. PubMed ID: 37040993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.